Showing results (181-190 of 274) with videos related to
Sort By:
Pageof 28
Clinical Pharmacology and Therapeutics|November 1, 1996
Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humansK Hartigan-Go, D N Bateman, G Nyberg, et al.Lancet (London, England)|April 25, 1992
Mutant debrisoquine hydroxylation genes in Parkinson's diseaseM Armstrong, A K Daly, S Cholerton, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 1, 1996
Influences on prescribing in non-fundholding general practicesM P Eccles, J Soutter, D N Bateman, et al.Public Health|February 3, 2009
Patterns and predictors of re-admission to hospital with self-poisoning in ScotlandR A Payne, J J Oliver, M Bain, et al.Emergency Medicine Journal : EMJ|February 27, 2008
Survey of cases of paracetamol overdose in the UK referred to National Poisons Information Service (NPIS) consultantsH K R Thanacoody, A M Good, W S Waring, et al.Clinical Pharmacokinetics|January 1, 1988
Population analysis of the pharmacokinetic variability of high-dose metoclopramide in cancer patientsJ Grevel, B Whiting, A W Kelman, et al.European Journal of Clinical Pharmacology|January 3, 1977
Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenololL Bertilsson, K Haglund, J Ostman, et al.European Journal of Clinical Pharmacology|August 14, 1975
Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl esterJ A Saavedra, J L Reid, W Jordan, et al.Biochemical Pharmacology|October 15, 1988
The acute and subchronic effects of ketoconazole on hepatic microsomal monooxygenases in the ratR G Thomson, M D Rawlins, O F James, et al.British Journal of Clinical Pharmacology|January 1, 1979
Mean steady-state plasma concentrations of labetalol in patients undergoing antihypertensive therapyG L Sanders, P A Routledge, A Ward, et al.Pageof 28